Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
Efficacy and safety of twice daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to the standard once-daily proton pump inhibitor : the EXTEND study in Japan